PCN35 DEVELOPMENT AND VALIDATION OF A DISEASE-SPECIFIC, NEUROENDOCRINE TUMOR QUESTIONNAIRE (QOL-NET). TO MEASURE PATIENTS' PERCEPTION OF THE EFFECTS OF DISEASE ON THEIR QUALITY OF LIFE (QOL)
May 1, 2006, 00:00
10.1016/S1098-3015(10)64659-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)64659-1/fulltext
Title :
PCN35 DEVELOPMENT AND VALIDATION OF A DISEASE-SPECIFIC, NEUROENDOCRINE TUMOR QUESTIONNAIRE (QOL-NET). TO MEASURE PATIENTS' PERCEPTION OF THE EFFECTS OF DISEASE ON THEIR QUALITY OF LIFE (QOL)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64659-1&doi=10.1016/S1098-3015(10)64659-1
First page :
Section Title :
Open access? :
No
Section Order :
64